Gastroparesis Market Size | Segmentation, Outlook, Industry Report

The Gastroparesis Market was valued at US$ 4,338.61 million in 2019 and is projected to reach US$ 6,025.11 million by 2027; it is expected to grow at a CAGR of 4.3%during 2020-2027.

The growth of the market is mainly attributed to the increasing prevalence of diabetes and growing geriatric population. However, side effects of gastroparesis drugs obstruct the growth of the market.

Get Exclusive Sample PDF @: https://www.premiummarketinsights.com/sample/TIP00024714?utm_source=OpenPr&utm_medium=10640

Analysis of the Top Market Players:

1. EVOKE PHARMA
2. Bausch Health Companies Inc. (Salix Pharmaceuticals, Ltd.)
3. Johnson and Johnson Services, Inc.
4. Allergan Plc
5. NEUROGASTRX, INC.
6. TEVA PHARMACEUTICAL INDUSTRIES LTD
7. Pfizer Inc.
8. ANI Pharmaceuticals, Inc.
9. Ipca Laboratories Ltd.
10. Cinrx Pharma, LLC (Cindome Pharma)

In this report, the market has been segmented on the basis of:

Gastroparesis Type (Idiopathic, Diabetic, Post-Surgical, and Others)
Drug Class Type (Prokinetic Agents, Botulinum Toxin Injections, and Antiemetic Agents)
Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Others)

Access full Report Description, TOC, Table of Figure, Chart, etc. @: https://www.premiummarketinsights.com/reports-tip/gastroparesis-market

Diabetes mellitus is a life-threatening chronic disease mainly caused by the body's inability to produce insulin or effectively utilize it. Diabetes is one of the global health emergencies of the 21st century. According to a report published by International Diabetes Federation (IDF) in 2019, 1 in 11 people in the world are suffering from diabetes. The total global count of people suffering from diabetes was around 463 million in 2019. Moreover, according to the same report, the prevalence of disease is expected grow by 35% by 2045. The data also suggests that almost 84 million people in Southeast Asia are diabetic; among these, 149,300 are children, and they require a daily dosage of insulin shots. In addition, the National Institutes of Health (NIH) also reported that the incidence of type 1 diabetes is increasing rapidly, and the disease is affecting a significant number of children and teenagers.

Order a copy of this research report at @: https://www.premiummarketinsights.com/buy/TIP00024714?utm_source=OpenPr&utm_medium=10640

Contact Us:
If you have any queries about this report or if you would like further information, please
Contact Person: Ankit Mathur
Phone: +1-646-491-9876
Email: sales@premiummarketinsights.com

About Us:
Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost-effective research reports and solutions from various publishers.
The market research industry has changed in last decade. As corporate focus has shifted to niche markets and emerging countries, a number of publishers have stepped in to fulfil these information needs. We have experienced and trained staff that helps you navigate different options and lets you choose best research solution at most effective cost.
Premium Market Insights has an extensive coverage of industry reports, company reports and country reports across all industries. In case your research needs are not met by syndicated reports offered by leading publishers, we can help you by offering a customized research solution by liaising with different research agencies saving your valuable time and money.
We provide best in class customer service and our customer support team is always available to help you on your research queries. Our commitment to customer service is best exemplified by free analyst support that we offer to our clients which sets us apart from any other provider. We also offer enterprise subscriptions which provide significant cost savings to our clients.

This release was published on openPR.